Generatixe Inc.
Generative Biology
Generative Life Code
GENERATIVE
Protein, Antibody, RNA, DNA,...
Generative Biology
Generative biology combines advanced computational techniques like AI and machine learning with biological data to create novel biological systems. This field enables the design of new proteins, the engineering of microorganisms, and the simulation of complex biological processes, offering innovative solutions in healthcare, agriculture, and sustainability. As it evolves, generative biology promises to revolutionize how we understand and manipulate the building blocks of life, ushering in a new era of scientific innovation and practical applications.
Generative Platforms
Generative Proteins
AI-driven synthesis of novel proteins for therapeutic and industrial uses.
Generative RNA
Computational design of RNA sequences for gene regulation and therapy.
Programming cells to perform specific tasks in medicine and biotechnology.
Generative Cell
Target Industries
Gene Therapy
Gene therapy will require advancements in both gene payload optimization and the vectors that deliver ssDNA or dsDNA to target cells. In this field, we will generate de novo genes and develop generative vectors.
Cell Therapy
This field will be predominantly dominated by cell-based immunotherapy and cell reprogramming. We will produce more efficient CAR and TCR constructs based on generative antibodies and nanobodies, and will accelerate in vivo cell reprogramming.
RNA Therapy
RNA, in both linear and circular forms, will be the focus of optimization with our generative platform. We will develop more platforms for cis and trans RNA self-replication to enhance the capacity of mRNA and RNAi therapeutics.
Next Generation Medicine
Next-generation medicine is poised to revolutionize healthcare through the integration of generative biology, which leverages AI to create novel biological systems and components.
Let’s Imagine it!
Generative AI is being utilized to design precise and personalized therapies, including innovative gene and cell therapies that can target diseases at their genetic roots.
Let’s Do it!
Current CAR T cell therapy costs approximately $400,000, and AAV-based gene therapy ranges from $2 to $4 million. These exorbitant prices cause immense frustration and disappointment for parents and families dealing with cancer and genetic diseases. To democratize access to these life-saving treatments for the majority of citizens and their patients, cell and gene therapy products must be priced below $10,000.
We will deliver it!
